| 9001 | LYZL2 levels | GCST90469833 | 0.05 |
| 9002 | Concentration of small LDL particles | GCST90092963 | 0.05 |
| 9003 | DBNL/HEXIM1 ratio | GCST90314417 | 0.05 |
| 9004 | Main speciality of consultant (recoded) - General medicine | Summary Administration | UKBB00000416 | 0.05 |
| 9005 | LCN2/PGLYRP1 ratio | GCST90315306 | 0.05 |
| 9006 | DAG1/MGLL ratio | GCST90314377 | 0.05 |
| 9007 | Takes medication for high cholesterol? | GCST90475208 | 0.05 |
| 9008 | Fruit juice liking | GCST90094768 | 0.05 |
| 9009 | Triglyceride levels in very small VLDL | GCST90132669 | 0.05 |
| 9010 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T173 | ECGU000173 | 0.05 |
| 9011 | FKBP5/ZBTB16 ratio | GCST90314850 | 0.05 |
| 9012 | T1 FreeSurfer BA lh V1 exvivo area | GCST90385514 | 0.05 |
| 9013 | Other disorders of fluid, electrolyte and acid-base balance | FING00001027 | 0.05 |
| 9014 | DLL1/NOTCH1 ratio | GCST90314498 | 0.05 |
| 9015 | PPP1R2/TMSB10 ratio | GCST90315721 | 0.05 |
| 9016 | Blood urea nitrogen (BUN, mean, inv-norm transformed) | GCST90475165 | 0.05 |
| 9017 | CD84 levels | GCST90468653 | 0.05 |
| 9018 | aparc-a2009s rh area G-pariet-inf-Supramar | GCST90003396 | 0.05 |
| 9019 | aseg global volume CC-Anterior | GCST90002611 | 0.05 |
| 9020 | IDP dMRI ProbtrackX ICVF cst l | GCST90004383 | 0.05 |
| 9021 | DNAJA2/PRDX5 ratio | GCST90314506 | 0.05 |
| 9022 | 4-androsten-3beta,17beta-diol disulfate 1 levels | GCST90243879 | 0.05 |
| 9023 | Frequency of tiredness / lethargy in last 2 weeks | Mental health | UKBB00000268 | 0.05 |
| 9024 | Reaction time (baseline) | GCST90565838 | 0.05 |
| 9025 | LDL (standard GWA) | GCST90267272 | 0.05 |
| 9026 | DAPP1/PMVK ratio | GCST90314396 | 0.05 |
| 9027 | Frailty (Factor 1 - Limited Social Support) | GCST90624047 | 0.05 |
| 9028 | ERBB4/NELL1 ratio | GCST90314691 | 0.05 |
| 9029 | Spleen volume | GCST90016667 | 0.05 |
| 9030 | Overweight, obesity and other hyperalimentation (PheCode 278) | GCST90475759 | 0.05 |
| 9031 | Diseases of male genital organs | FING00000426 | 0.05 |
| 9032 | CDH2/SSC4D ratio | GCST90313951 | 0.05 |
| 9033 | X-12844 levels | GCST90200523 | 0.05 |
| 9034 | BLMH/SERPINE1 ratio | GCST90313520 | 0.05 |
| 9035 | Never eat eggs, dairy, wheat, sugar - I eat all of the above | Diet | UKBB00000500 | 0.05 |
| 9036 | Sphingomyelins levels | GCST90499983 | 0.05 |
| 9037 | Other diseases of intestine | Other diseases of intestines | UKBB00000605 | 0.05 |
| 9038 | Paracetamol of NSAID medication | FING00001145 | 0.05 |
| 9039 | BAX/MAX ratio | GCST90313466 | 0.05 |
| 9040 | T1 FreeSurfer DKT rh lingual area | GCST90384297 | 0.05 |
| 9041 | Non-cancer illness code, self-reported - type 2 diabetes | Medical conditions | UKBB00000522 | 0.05 |
| 9042 | T1 FreeSurfer DK rh fusiform volume | GCST90385763 | 0.05 |
| 9043 | Type 2 diabetes (PheCode 250.2) | GCST90475667 | 0.05 |
| 9044 | Waking up during the night and not easily going back to sleep | GCST90476386 | 0.05 |
| 9045 | CA13/TYMP ratio | GCST90313568 | 0.05 |
| 9046 | Intelligence | GCST90179114 | 0.05 |
| 9047 | BIN2/TMSB10 ratio | GCST90313515 | 0.05 |
| 9048 | Whole body fat mass | Impedance measures | UKBB00000914 | 0.05 |
| 9049 | Feeling nervous | GCST006948 | 0.05 |
| 9050 | PSME1 levels | GCST90470360 | 0.05 |
| 9051 | DTI autoptx L1 cst l tract | GCST90385147 | 0.05 |
| 9052 | Volume of left central nucleus | GCST90474961 | 0.05 |
| 9053 | Prescriptions - paracetamol | antipyretic | UKBB00000696 | 0.05 |
| 9054 | Prescriptions - antipyretic | UKBB00000665 | 0.05 |
| 9055 | Usual walking pace | Physical activity | UKBB00000891 | 0.05 |
| 9056 | Cholesterol in medium LDL (UKB data field 23540) | GCST90269637 | 0.05 |
| 9057 | DARS1/USP8 ratio | GCST90314407 | 0.05 |
| 9058 | Skin color (cheek, ITA value) | GCST90502780 | 0.05 |
| 9059 | Docosahexaenoic acid levels | GCST90502242 | 0.05 |
| 9060 | FKBP4/FKBP5 ratio | GCST90314838 | 0.05 |
| 9061 | IDP dMRI ProbtrackX ISOVF fmi | GCST90004536 | 0.05 |
| 9062 | Volume of left lateral nucleus | GCST90474973 | 0.05 |
| 9063 | CD40/IGSF8 ratio | GCST90313815 | 0.05 |
| 9064 | DTI TBSS L3 Splenium of corpus callosum | GCST90384528 | 0.05 |
| 9065 | 1,5-anhydroglucitol (1,5-ag) levels | GCST90243529 | 0.05 |
| 9066 | SCLY levels | GCST90470546 | 0.05 |
| 9067 | wg rh intensity-contrast precentral | GCST90003850 | 0.05 |
| 9068 | COL18A1/RARRES2 ratio | GCST90314169 | 0.05 |
| 9069 | Monocyte percentage (UKB data field 30190) | GCST90468091 | 0.05 |
| 9070 | B2M levels | GCST90468409 | 0.05 |
| 9071 | DUSP29 levels | GCST90469052 | 0.05 |
| 9072 | FABP3 levels | GCST90469175 | 0.05 |
| 9073 | PIKFYVE levels | GCST90470235 | 0.05 |
| 9074 | Volume of left paralaminar nucleus | GCST90474985 | 0.05 |
| 9075 | Other degenerative diseases of the nervous system | FING00000994 | 0.05 |
| 9076 | NPC2 levels | GCST90470068 | 0.05 |
| 9077 | IDP dMRI TBSS MO Body of corpus callosum | GCST90003955 | 0.05 |
| 9078 | Drive faster than motorway speed limit | Physical activity | UKBB00000194 | 0.05 |
| 9079 | HYOU1/TGFBR3 ratio | GCST90315105 | 0.05 |
| 9080 | Diabetic retinopathy (PheCode 250.7) | GCST90475689 | 0.05 |
| 9081 | Rheumatoid arthritis and other inflammatory (PheCode 714) | GCST90476228 | 0.05 |
| 9082 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90499299 | 0.05 |
| 9083 | IDP dMRI TBSS L3 Genu of corpus callosum | GCST90004173 | 0.05 |
| 9084 | Principal component-derived dietary pattern 31 | GCST90133036 | 0.05 |
| 9085 | Cholesterol to total lipids ratio in small HDL | GCST90092945 | 0.05 |
| 9086 | CD300C/MANSC1 ratio | GCST90313791 | 0.05 |
| 9087 | LGALS7_LGALS7B/WFDC12 ratio | GCST90315317 | 0.05 |
| 9088 | MSRA/PRDX5 ratio | GCST90315497 | 0.05 |
| 9089 | rfMRI connectivity ICA-features 6 | GCST90006344 | 0.05 |
| 9090 | F-fatty/salty food liking (derived food-liking factor) | GCST90094759 | 0.05 |
| 9091 | Cholesteryl esters in medium VLDL (UKB data field 23506) | GCST90269603 | 0.05 |
| 9092 | IDP SWI T2star right thalamus | GCST90003864 | 0.05 |
| 9093 | IL18R1 levels | GCST90469565 | 0.05 |
| 9094 | AGXT levels | GCST90468258 | 0.05 |
| 9095 | ERBB2/PTPRF ratio | GCST90314688 | 0.05 |
| 9096 | Phospholipids in medium LDL (UKB data field 23539) | GCST90269636 | 0.05 |
| 9097 | Never eat sugar vs no sugar restrictions (UKB data field 6144) | GCST90132934 | 0.05 |
| 9098 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T228 | ECGU000228 | 0.05 |
| 9099 | Nonischemic cardiomyopathy | FING00000883 | 0.05 |
| 9100 | Phosphatidylethanolamine (38:4) levels | GCST90488261 | 0.05 |
| 9101 | CD40 levels | GCST90012065 | 0.05 |
| 9102 | CEP43 levels | GCST90468715 | 0.05 |
| 9103 | Left-hemisphere limbic network to amygdala white-matter structural connectivity | GCST90302741 | 0.05 |
| 9104 | Estimated glomerular filtration rate (creatinine, cystatin c) | GCST90428446 | 0.05 |
| 9105 | DTI TBSS FA Sagittal stratum L | GCST90384411 | 0.05 |
| 9106 | IDP T1 FAST ROIs L temporal pole | GCST90002465 | 0.05 |
| 9107 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T469 | ECGA000469 | 0.05 |
| 9108 | F-cheese liking (derived food-liking factor) | GCST90094729 | 0.05 |
| 9109 | Viral hepatitis C (PheCode 70.3) | GCST90475553 | 0.05 |
| 9110 | CEBPB levels | GCST90468700 | 0.05 |
| 9111 | Soft tissue disorders | FING00001316 | 0.05 |
| 9112 | CXCL3/MGLL ratio | GCST90314345 | 0.05 |
| 9113 | PXN levels | GCST90470396 | 0.05 |
| 9114 | Diabetes mellitus (PheCode 250) | GCST90475658 | 0.05 |
| 9115 | Weekly usage of mobile phone in last 3 months | Electronic device use | UKBB00000908 | 0.05 |
| 9116 | Age high blood pressure diagnosed | Medical conditions | UKBB00000016 | 0.05 |
| 9117 | HippSubfield rh volume GC-ML-DG-head | GCST90002701 | 0.05 |
| 9118 | Exposure to tobacco smoke outside home | Smoking | UKBB00000229 | 0.05 |
| 9119 | Total testosterone levels | GCST90012113 | 0.05 |
| 9120 | Rotator cuff syndrome | FING00001270 | 0.05 |
| 9121 | wg rh intensity-contrast medialorbitofrontal | GCST90003840 | 0.05 |
| 9122 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T218 | ECGA000218 | 0.05 |
| 9123 | Recurrent or chronic depression | FING00001243 | 0.05 |
| 9124 | aparc-a2009s lh volume G-parietal-sup | GCST90002951 | 0.05 |
| 9125 | POF1B levels | GCST90470281 | 0.05 |
| 9126 | X-12038 levels | GCST90243683 | 0.05 |
| 9127 | CD163/DSC2 ratio | GCST90313733 | 0.05 |
| 9128 | Chronic Kidney Disease, Stage III (PheCode 585.33) | GCST90476128 | 0.05 |
| 9129 | Hyperlipidemia (PheCode 272.1) | GCST90475718 | 0.05 |
| 9130 | IDP dMRI ProbtrackX L1 cgc l | GCST90004250 | 0.05 |
| 9131 | FOXO1/NFATC1 ratio | GCST90314873 | 0.05 |
| 9132 | CD84/SORT1 ratio | GCST90313918 | 0.05 |
| 9133 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) levels (UKB data field 23402) | GCST90269499 | 0.05 |
| 9134 | Able to confide | Social support | UKBB00000004 | 0.05 |
| 9135 | Tea intake | Diet | UKBB00000814 | 0.05 |
| 9136 | SIGLEC5 levels | GCST90470633 | 0.05 |
| 9137 | Sphingomyelin (d18:1/16:0) levels | GCST90025744 | 0.05 |
| 9138 | Mean platelet (thrombocyte) volume | Blood count | UKBB00000450 | 0.05 |
| 9139 | Frailty (Factor 6 - Disability) | GCST90624052 | 0.05 |
| 9140 | LDL cholesterol | GCST000759 | 0.05 |
| 9141 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T87 | ECGU000087 | 0.05 |
| 9142 | Alanine aminotransferase levels | GCST90278617 | 0.05 |
| 9143 | DPP6/NRCAM ratio | GCST90314542 | 0.05 |
| 9144 | BACH1/CD2AP ratio | GCST90313435 | 0.05 |
| 9145 | Bleeding | FING00000219 | 0.05 |
| 9146 | Pain type(s) experienced in last month - Hip pain | Pain | UKBB00000628 | 0.05 |
| 9147 | Cholesteryl Esters in Small VLDL | GCST90499782 | 0.05 |
| 9148 | LMNB1 levels | GCST90469781 | 0.05 |
| 9149 | Friendships satisfaction | Mental health | UKBB00000273 | 0.05 |
| 9150 | Mean platelet volume during third trimester of pregnancy | GCST90302231 | 0.05 |
| 9151 | Right-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302805 | 0.05 |
| 9152 | Brussel sprout liking | GCST90094714 | 0.05 |
| 9153 | TFF2 levels | GCST90470836 | 0.05 |
| 9154 | FCAMR levels | GCST90469196 | 0.05 |
| 9155 | Estimated glomerular filtration rate (cystatin c) | GCST90428448 | 0.05 |
| 9156 | Triglycerides to total lipids ratio in medium VLDL | GCST90092927 | 0.05 |
| 9157 | IDP dMRI TBSS L3 Splenium of corpus callosum | GCST90004175 | 0.05 |
| 9158 | DNPH1/NSFL1C ratio | GCST90314526 | 0.05 |
| 9159 | LCN15 levels | GCST90469746 | 0.05 |
| 9160 | Acute pancreatitis | FING00000027 | 0.05 |
| 9161 | Other specified/unspecified inflammatory spondylopathies | FING00001109 | 0.05 |
| 9162 | Total lipids in large LDL (UKB data field 23531) | GCST90269628 | 0.05 |
| 9163 | F-low caloric food liking (derived food-liking factor) | GCST90094795 | 0.05 |
| 9164 | EBAG9/HBEGF ratio | GCST90314565 | 0.05 |
| 9165 | Parkinson's disease | FING00001150 | 0.05 |
| 9166 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T419 | ECGU000419 | 0.05 |
| 9167 | Disorders of lipid metabolism (PheCode 272) | GCST90475715 | 0.05 |
| 9168 | Hearing aid user | Hearing | UKBB00000309 | 0.05 |
| 9169 | BTN2A1/SIGLEC1 ratio | GCST90313548 | 0.05 |
| 9170 | Treatment/medication code - salbutamol | Medications | UKBB00000857 | 0.05 |
| 9171 | aparc-pial rh area superiorparietal | GCST90003202 | 0.05 |
| 9172 | Current employment status - Unable to work because of sickness or disability | Employment | UKBB00000160 | 0.05 |
| 9173 | F-lentils/beans liking (derived food-liking factor) | GCST90094793 | 0.05 |
| 9174 | STC1 levels | GCST90470761 | 0.05 |
| 9175 | Salad dressing liking | GCST90094822 | 0.05 |
| 9176 | Mean arterial pressure, manual reading | Cardiovascular measurement | UKBB00000441 | 0.05 |
| 9177 | Mean time to correctly identify matches | Reaction time | UKBB00000453 | 0.05 |
| 9178 | Concentration of IDL particles (UKB data field 23523) | GCST90269620 | 0.05 |
| 9179 | Urinary calculus (PheCode 594) | GCST90476143 | 0.05 |
| 9180 | Phospholipids in LDL (UKB data field 23413) | GCST90269510 | 0.05 |
| 9181 | PDCD6IP levels | GCST90618969 | 0.05 |
| 9182 | Body mass index | GCST004904 | 0.05 |
| 9183 | aparc-DKTatlas lh area parstriangularis | GCST90003252 | 0.05 |
| 9184 | T1 FreeSurfer DKT rh lateraloccipital area | GCST90384295 | 0.05 |
| 9185 | Cholesterol to total lipids ratio in medium VLDL | GCST90092917 | 0.05 |
| 9186 | PPP1R12A/VEGFC ratio | GCST90315715 | 0.05 |
| 9187 | Thyrotoxicosis with or without goiter (PheCode 242) | GCST90475643 | 0.05 |
| 9188 | Abdominal and pelvic pain | Symptoms and signs involving the digestive system and abdomen | UKBB00000001 | 0.05 |
| 9189 | CDHR1 levels | GCST90468678 | 0.05 |
| 9190 | Principal component-derived dietary pattern 11 | GCST90133016 | 0.05 |
| 9191 | Cholesteryl ester levels in small LDL | GCST90092958 | 0.05 |
| 9192 | Soft cheese liking | GCST90094843 | 0.05 |
| 9193 | Nephritis and nephropathy in diseases classified elsewhere (PheCode 580.31) | GCST90476116 | 0.05 |
| 9194 | rfMRI connectivity (ICA100 edge 659) | GCST90005512 | 0.05 |
| 9195 | Renal failure (PheCode 585) | GCST90476118 | 0.05 |
| 9196 | HYOU1 levels | GCST90469496 | 0.05 |
| 9197 | GP6/LGALS8 ratio | GCST90314964 | 0.05 |
| 9198 | PDCD1/TNFRSF4 ratio | GCST90315609 | 0.05 |
| 9199 | TNFRSF17 levels | GCST90470908 | 0.05 |
| 9200 | HippSubfield rh volume CA3-body | GCST90002702 | 0.05 |
| 9201 | Cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23580) | GCST90269677 | 0.05 |
| 9202 | Red cell distribution width variance | GCST90565705 | 0.05 |
| 9203 | Alzheimer's disease (MTAG) | GCST90449058 | 0.05 |
| 9204 | Cholesterol in small LDL (UKB data field 23547) | GCST90269644 | 0.05 |
| 9205 | DKK1/VEGFA ratio | GCST90314483 | 0.05 |
| 9206 | Triglyceride levels in medium HDL | GCST90092902 | 0.05 |
| 9207 | ITGB1/SELP ratio | GCST90315230 | 0.05 |
| 9208 | Omega-3 fatty acid levels | GCST90502423 | 0.05 |
| 9209 | FOLH1 levels | GCST90469258 | 0.05 |
| 9210 | Pain type(s) experienced in last month - Neck or shoulder pain | Pain | UKBB00000630 | 0.05 |
| 9211 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171 | ECGA000171 | 0.05 |
| 9212 | PDGFB/TNFSF13 ratio | GCST90315632 | 0.05 |
| 9213 | IGF2R/LGMN ratio | GCST90315131 | 0.05 |
| 9214 | Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555) | GCST90476065 | 0.05 |
| 9215 | Total cholines levels | GCST90092812 | 0.05 |
| 9216 | Hearing difficulty/problems: No (UKB data field 2247_0) | GCST90042881 | 0.05 |
| 9217 | BMI (standard GWA) | GCST90267268 | 0.05 |
| 9218 | C1R levels | GCST90468493 | 0.05 |
| 9219 | EIF4G1/NFATC1 ratio | GCST90314637 | 0.05 |
| 9220 | Omega-3 fatty acids to total fatty acids percentage | GCST90502462 | 0.05 |
| 9221 | Tyrosine levels | GCST90200427 | 0.05 |
| 9222 | Chained arithmetic | Fluid intelligence / reasoning | UKBB00000126 | 0.05 |
| 9223 | HS6ST1 levels | GCST90469479 | 0.05 |
| 9224 | CKAP4/IL4R ratio | GCST90314072 | 0.04 |
| 9225 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T452 | ECGA000452 | 0.04 |
| 9226 | DSC2/EFEMP1 ratio | GCST90314555 | 0.04 |
| 9227 | Hair colour (natural, before greying): Blonde (UKB data field 1747_1) | GCST90041836 | 0.04 |
| 9228 | Plasma betaine levels in chronic kidney disease | GCST90264858 | 0.04 |
| 9229 | T1 FreeSurfer DK rh pericalcarine area | GCST90385709 | 0.04 |
| 9230 | Type 2 diabetes | GCST005413 | 0.04 |
| 9231 | Apples liking | GCST90094691 | 0.04 |
| 9232 | DTI TBSS MD Posterior limb of internal capsule R | GCST90384590 | 0.04 |
| 9233 | Phosphoglycerides levels | GCST90499259 | 0.04 |
| 9234 | TNFRSF11A levels | GCST90277644 | 0.04 |
| 9235 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T212 | ECGU000212 | 0.04 |
| 9236 | Hearing difficulty/problems: Yes (UKB data field 2247_1) | GCST90042882 | 0.04 |
| 9237 | GALNT3 levels | GCST90469297 | 0.04 |
| 9238 | Cholesterol in Large VLDL | GCST90498119 | 0.04 |
| 9239 | NOS1 levels | GCST90470062 | 0.04 |
| 9240 | Linoleic acid levels | GCST90502295 | 0.04 |
| 9241 | IDP dMRI ProbtrackX OD fmi | GCST90004461 | 0.04 |
| 9242 | Skin colour | Sun exposure | UKBB00000773 | 0.04 |
| 9243 | ARG1 levels | GCST90468350 | 0.04 |
| 9244 | Hematocrit | GCST90002383 | 0.04 |
| 9245 | Body mass index (UKB data field 21001) | GCST90468161 | 0.04 |
| 9246 | Depressive symptomatology (confirmatory factor analysis Factor 2) | GCST90309337 | 0.04 |
| 9247 | Hematocrit | GCST90002304 | 0.04 |
| 9248 | CD40/TNFRSF14 ratio | GCST90313830 | 0.04 |
| 9249 | CDNF levels | GCST90468686 | 0.04 |
| 9250 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T121 | ECGU000121 | 0.04 |
| 9251 | NUDT5/SERPINB1 ratio | GCST90315581 | 0.04 |
| 9252 | Cerebral ischemia (PheCode 433.3) | GCST90475988 | 0.04 |
| 9253 | Disorders of plasma protein metabolism (PheCode 270.3) | GCST90475709 | 0.04 |
| 9254 | Body mass index (MTAG) | GCST90179150 | 0.04 |
| 9255 | CALB1 levels | GCST90468526 | 0.04 |
| 9256 | GPC1 levels | GCST90469386 | 0.04 |
| 9257 | T1 FreeSurfer DK rh lateraloccipital area | GCST90385699 | 0.04 |
| 9258 | MARCO levels | GCST90469861 | 0.04 |
| 9259 | Time spent using computer | Physical activity | UKBB00000820 | 0.04 |
| 9260 | red cell diameter width (RDW, mean, inv-norm transformed) | GCST90476361 | 0.04 |
| 9261 | Phospholipids in large HDL | GCST90497847 | 0.04 |
| 9262 | Cholesteryl ester levels in medium LDL | GCST90092906 | 0.04 |
| 9263 | HippSubfield rh volume CA1-head | GCST90002696 | 0.04 |
| 9264 | Lymphocyte count | GCST90025984 | 0.04 |
| 9265 | ITGB1BP2/MITD1 ratio | GCST90315214 | 0.04 |
| 9266 | IDP dMRI TBSS MO Cerebral peduncle R | GCST90003966 | 0.04 |
| 9267 | Total cholesterol levels | GCST90018754 | 0.04 |
| 9268 | DAG1/PLA2G4A ratio | GCST90314380 | 0.04 |
| 9269 | Triglyceride levels in very small VLDL | GCST90093038 | 0.04 |
| 9270 | TIGIT levels | GCST90470865 | 0.04 |
| 9271 | FAS levels | GCST90090701 | 0.04 |
| 9272 | aparc-DKTatlas lh volume superiorparietal | GCST90002889 | 0.04 |
| 9273 | aparc-DKTatlas rh volume supramarginal | GCST90002922 | 0.04 |
| 9274 | MED18/TACC3 ratio | GCST90315414 | 0.04 |
| 9275 | RGMB levels | GCST90242647 | 0.04 |
| 9276 | HEXIM1/IPCEF1 ratio | GCST90315046 | 0.04 |
| 9277 | Low-density lipoprotein levels (MTAG) | GCST90179148 | 0.04 |
| 9278 | F-bitter food liking (derived food-liking factor) | GCST90094706 | 0.04 |
| 9279 | 1-arachidonoylglycerophosphocholine levels | GCST90243674 | 0.04 |
| 9280 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T173 | ECGA000173 | 0.04 |
| 9281 | Multiple myeloma or monoclonal gammopathy of undetermined significance | GCST90624746 | 0.04 |
| 9282 | Polyunsaturated fatty acid levels | GCST90502607 | 0.04 |
| 9283 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T184 | ECGA000184 | 0.04 |
| 9284 | F-acquired taste liking (derived food-liking factor) | GCST90094791 | 0.04 |
| 9285 | Right-hemisphere dorsal attention network to amygdala white-matter structural connectivity | GCST90302811 | 0.04 |
| 9286 | ALCAM/CNTN1 ratio | GCST90313235 | 0.04 |
| 9287 | Deaf mutism, not elsewhere classified | FING00000378 | 0.04 |
| 9288 | Gamma glutamyl transferase levels | GCST90278630 | 0.04 |
| 9289 | CD163/MSR1 ratio | GCST90313738 | 0.04 |
| 9290 | CA9 levels | GCST90468518 | 0.04 |
| 9291 | Omega-6 fatty acid levels | GCST90502503 | 0.04 |
| 9292 | ADGRG2/SDC1 ratio | GCST90313187 | 0.04 |
| 9293 | aseg lh volume Hippocampus | GCST90002624 | 0.04 |
| 9294 | Other dyspnea (PheCode 512.9) | GCST90476042 | 0.04 |
| 9295 | Hyperthyroidism | GCST90468136 | 0.04 |
| 9296 | KCTD5 levels | GCST90469670 | 0.04 |
| 9297 | Citrulline levels | GCST90243458 | 0.04 |
| 9298 | Blood cell traits latent factor 10 (platelet) | GCST90559252 | 0.04 |
| 9299 | Trans-2-hexenoylglycine metabolite level | GCST90616136 | 0.04 |
| 9300 | Monocyte percentage of white cells | GCST90002394 | 0.04 |
| 9301 | Phosphatidylinositol-O_36:0_[M-H]1- levels | GCST90060480 | 0.04 |
| 9302 | IL10 levels | GCST90469546 | 0.04 |
| 9303 | Brainstem global volume Medulla | GCST90002764 | 0.04 |
| 9304 | GPKOW/PXN ratio | GCST90314978 | 0.04 |
| 9305 | Ovarian dysfunction | FING00001133 | 0.04 |
| 9306 | ThalamNuclei lh volume Whole-thalamus | GCST90002762 | 0.04 |
| 9307 | Chronic iridocyclitis | FING00000287 | 0.04 |
| 9308 | MMP13 levels | GCST90469917 | 0.04 |
| 9309 | IDP T1 FAST ROIs brain stem | GCST90002561 | 0.04 |
| 9310 | Coriander liking | GCST90094744 | 0.04 |
| 9311 | Neuroticism | GCST003770 | 0.04 |
| 9312 | Multi-trait sum score | GCST90270117 | 0.04 |
| 9313 | Idiopathic pulmonary fibrosis | FING00000659 | 0.04 |
| 9314 | Atrial fibrillation/atrial flutter | GCST90018576 | 0.04 |
| 9315 | DTI TBSS L1 Posterior thalamic radiation L | GCST90384457 | 0.04 |
| 9316 | Myocardial fractal dimension (slice 4) | GCST90000290 | 0.04 |
| 9317 | FXYD5/TMSB10 ratio | GCST90314906 | 0.04 |
| 9318 | Total lipids in lipoprotein particles (UKB data field 23423) | GCST90269520 | 0.04 |
| 9319 | F2R/ITGB1BP2 ratio | GCST90314731 | 0.04 |
| 9320 | ADH4/RBP5 ratio | GCST90313194 | 0.04 |
| 9321 | Cerebrospinal fluid proline levels | GCST90318251 | 0.04 |
| 9322 | CHMP1A/EREG ratio | GCST90314048 | 0.04 |
| 9323 | OMG levels | GCST90470124 | 0.04 |
| 9324 | Non-cancer illness code, self-reported - kidney stone/ureter stone/bladder stone | Medical conditions | UKBB00000519 | 0.04 |
| 9325 | mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed) | GCST90475454 | 0.04 |
| 9326 | Visceral adipose tissue volume | GCST90016671 | 0.04 |
| 9327 | NCAN levels | GCST90618559 | 0.04 |
| 9328 | LYPD8 levels | GCST90469829 | 0.04 |
| 9329 | ANXA3/SERPINB1 ratio | GCST90313289 | 0.04 |
| 9330 | ARHGEF12/DECR1 ratio | GCST90313349 | 0.04 |
| 9331 | Heart rate variability (root mean square of successive differences) | GCST90281263 | 0.04 |
| 9332 | Triglycerides to total lipids ratio in small LDL | GCST90092967 | 0.04 |
| 9333 | Length of time at current address | Household | UKBB00000404 | 0.04 |
| 9334 | Falls in the last year | General health | UKBB00000235 | 0.04 |
| 9335 | F-glutamate liking (derived food-liking factor) | GCST90094772 | 0.04 |
| 9336 | Cholesterol, total | GCST000760 | 0.04 |
| 9337 | ECG, load | ECG during exercise | UKBB00000205 | 0.04 |
| 9338 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T52 | ECGA000052 | 0.04 |
| 9339 | Volume of right whole amygdala | GCST90475057 | 0.04 |
| 9340 | PLAUR levels | GCST90012051 | 0.04 |
| 9341 | ESAM/TNFRSF14 ratio | GCST90314720 | 0.04 |
| 9342 | KLK8/NECTIN4 ratio | GCST90315258 | 0.04 |
| 9343 | Serum 25-Hydroxyvitamin D level variance | GCST90000621 | 0.04 |
| 9344 | IDP dMRI ProbtrackX ICVF atr r | GCST90004378 | 0.04 |
| 9345 | ABL1/PDLIM7 ratio | GCST90313150 | 0.04 |
| 9346 | Urine dimethylglycine levels in chronic kidney disease | GCST90265045 | 0.04 |
| 9347 | How many years have you or did you smoke cigarettes? (inv-normal transformed) | GCST90476390 | 0.04 |
| 9348 | Belittlement by partner or ex-partner as an adult | Traumatic events | UKBB00000091 | 0.04 |
| 9349 | Gestational diabetes (for exclusion) | FING00000573 | 0.04 |
| 9350 | Time to complete round | Pairs matching | UKBB00000822 | 0.04 |
| 9351 | Concentration of medium LDL particles | GCST90092911 | 0.04 |
| 9352 | Neonatal jaundice (paternal effect) | GCST90435147 | 0.04 |
| 9353 | Ratio of linoleic acid to total fatty acids | GCST90092881 | 0.04 |
| 9354 | DTI autoptx L2 slf r tract | GCST90385188 | 0.04 |
| 9355 | Lysophosphatidylcholine (22:6) [sn2] levels | GCST90024185 | 0.04 |
| 9356 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T278 | ECGU000278 | 0.04 |
| 9357 | BCAM/ICAM4 ratio | GCST90313472 | 0.04 |
| 9358 | TFF1 levels | GCST90470835 | 0.04 |
| 9359 | Sensorineural hearing loss (PheCode 389.1) | GCST90475911 | 0.04 |
| 9360 | Direct low density lipoprotein levels (UKB data field 30780) | GCST90468080 | 0.04 |
| 9361 | Cholesterol to total lipids ratio in large HDL | GCST90092845 | 0.04 |
| 9362 | Anorexia (incl.atypical) | FING00000093 | 0.04 |
| 9363 | Omega-6 fatty acid levels | GCST90502100 | 0.04 |
| 9364 | F-cake/biscuits liking (derived food-liking factor) | GCST90094722 | 0.04 |
| 9365 | Arm fat percentage (left) | Impedance measures | UKBB00000045 | 0.04 |
| 9366 | Free Cholesterol in LDL | GCST90498386 | 0.04 |
| 9367 | CD164/NUDT5 ratio | GCST90313742 | 0.04 |
| 9368 | Dried fruit liking | GCST90094756 | 0.04 |
| 9369 | DTI autoptx L2 ptr r tract | GCST90385186 | 0.04 |
| 9370 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320610 | 0.04 |
| 9371 | Acute tubulo-interstitial nephritis | FING00000033 | 0.04 |
| 9372 | Ground coffee consumption | GCST90132976 | 0.04 |
| 9373 | Benign neoplasm: Parotid gland | FING00000192 | 0.04 |
| 9374 | Hearing difficulty/problems | Hearing | UKBB00000310 | 0.04 |
| 9375 | Morning/evening person (chronotype) | Sleep | UKBB00000483 | 0.04 |
| 9376 | Platelet count | Blood count | UKBB00000646 | 0.04 |
| 9377 | IDP SWI T2star right pallidum | GCST90003870 | 0.04 |
| 9378 | BA-exvivo lh area BA3a | GCST90003209 | 0.04 |
| 9379 | Phospholipids in large LDL (UKB data field 23532) | GCST90269629 | 0.04 |
| 9380 | Benign neoplasm: salivary glands, exclude unknown (D119) | FING00000199 | 0.04 |
| 9381 | Sleep apnea | GCST90475824 | 0.04 |
| 9382 | TNFRSF4 levels | GCST90470913 | 0.04 |
| 9383 | EGLN1/FOXO1 ratio | GCST90314616 | 0.04 |
| 9384 | HippSubfield rh volume CA4-head | GCST90002704 | 0.04 |
| 9385 | METAP2/PLPBP ratio | GCST90315432 | 0.04 |
| 9386 | Cholesteryl Esters to Total Lipids in IDL percentage | GCST90497549 | 0.04 |
| 9387 | DTI TBSS MO Medial lemniscus L | GCST90384629 | 0.04 |
| 9388 | CD300A levels | GCST90468619 | 0.04 |
| 9389 | Pancreas iron content | GCST90016676 | 0.04 |
| 9390 | CD5 levels | GCST90274773 | 0.04 |
| 9391 | Mean arterial pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000443 | 0.04 |
| 9392 | PRCP levels | GCST90470314 | 0.04 |
| 9393 | CD99L2/RARRES2 ratio | GCST90313927 | 0.04 |
| 9394 | Symbol digit substitution test performance (baseline) | GCST90565841 | 0.04 |
| 9395 | Shoulder lesions | FING00001303 | 0.04 |
| 9396 | Any dementia (more control exclusions) | FING00000099 | 0.04 |
| 9397 | Dried fruit intake | Diet | UKBB00000193 | 0.04 |
| 9398 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T217 | ECGA000217 | 0.04 |
| 9399 | INPP1/NT5C3A ratio | GCST90315177 | 0.04 |
| 9400 | Lignoceroylcarnitine (C24) levels | GCST90200137 | 0.04 |
| 9401 | Anxiety disorders (more control exclusions) | FING00000098 | 0.04 |
| 9402 | Ever worried more than most people would in similar situation | Anxiety | UKBB00000227 | 0.04 |
| 9403 | Beetroot liking | GCST90094702 | 0.04 |
| 9404 | Vitamin B12 deficiency anaemia | FING00001441 | 0.04 |
| 9405 | Polyunsaturated fatty acids levels (UKB data field 23446) | GCST90269543 | 0.04 |
| 9406 | Haematocrit percentage | Blood count | UKBB00000292 | 0.04 |
| 9407 | Total Sphingomyelin levels | GCST90025842 | 0.04 |
| 9408 | Alzheimer's disease or family history of Alzheimer's disease | GCST007320 | 0.04 |
| 9409 | CHIT1 levels | GCST90468744 | 0.04 |
| 9410 | PCDH17 levels | GCST90470169 | 0.04 |
| 9411 | APOB levels | UKBB00000041 | 0.04 |
| 9412 | Arm fat mass (right) | Impedance measures | UKBB00000044 | 0.04 |
| 9413 | Monocyte percentage | Blood count | UKBB00000480 | 0.04 |
| 9414 | T1 FreeSurfer pial rh lateraloccipital area | GCST90385832 | 0.04 |
| 9415 | aparc-DKTatlas rh volume postcentral | GCST90002913 | 0.04 |
| 9416 | XXYLT1 levels | GCST90243370 | 0.04 |
| 9417 | Hair colour (natural, before greying) - Blonde | Sun exposure | UKBB00000296 | 0.04 |
| 9418 | Nasal polyps | respiratory | UKBB00000494 | 0.04 |
| 9419 | LDLR/MEGF9 ratio | GCST90315310 | 0.04 |
| 9420 | Congenital malformations of ovaries, fallopian tubes and broad ligaments | FING00000337 | 0.04 |
| 9421 | Lawsonibacter sp002161175 abundance in stool | GCST90032459 | 0.04 |
| 9422 | Phospholipid levels in medium LDL | GCST90092912 | 0.04 |
| 9423 | Total lipid levels in IDL | GCST90092837 | 0.04 |
| 9424 | Ulcerative colitis, NAS | FING00001390 | 0.04 |
| 9425 | AHSP/HMBS ratio | GCST90313217 | 0.04 |
| 9426 | ELOA/MAD1L1 ratio | GCST90314640 | 0.04 |
| 9427 | CLEC4M levels | GCST90468775 | 0.04 |
| 9428 | Other and unspecified psoriasis | FING00000950 | 0.04 |
| 9429 | Inflammatory bowel disease | GCST90432182 | 0.04 |
| 9430 | Phospholipids in medium VLDL | GCST90499024 | 0.04 |
| 9431 | IDP dMRI TBSS FA Posterior limb of internal capsule L | GCST90003896 | 0.04 |
| 9432 | Reaction time | GCST006268 | 0.04 |
| 9433 | Number of days/week of moderate physical activity 10+ minutes | Physical activity | UKBB00000533 | 0.04 |
| 9434 | GRAP2/MAP4K5 ratio | GCST90314982 | 0.04 |
| 9435 | aparc-DKTatlas rh area precentral | GCST90003287 | 0.04 |
| 9436 | Free cholesterol to total lipids ratio in medium VLDL | GCST90092921 | 0.04 |
| 9437 | CD38 levels | GCST90468628 | 0.04 |
| 9438 | BCR/NFATC1 ratio | GCST90313496 | 0.04 |
| 9439 | PGF levels | GCST90470218 | 0.04 |
| 9440 | Autoimmune polyglandular failure | FING00000135 | 0.04 |
| 9441 | EGF/GP6 ratio | GCST90314608 | 0.04 |
| 9442 | LGMN levels | GCST90469766 | 0.04 |
| 9443 | eGFR in diabetes mellitus (loose) case-control group (minimal adjustment) | GCST90624790 | 0.04 |
| 9444 | Number of non-cancer illnesses (weighted GWA) | GCST90267291 | 0.04 |
| 9445 | HMBS/UBAC1 ratio | GCST90315066 | 0.04 |
| 9446 | X-11787 levels | GCST90200465 | 0.04 |
| 9447 | Provencibacterium massiliense abundance in stool | GCST90032527 | 0.04 |
| 9448 | DDR1/PVR ratio | GCST90314442 | 0.04 |
| 9449 | SERPIND1 levels | GCST90470595 | 0.04 |
| 9450 | SHISA5 levels | GCST90470626 | 0.04 |
| 9451 | Mean volume of bilateral amygdala | GCST90474997 | 0.04 |
| 9452 | DTI autoptx L3 ptr l tract | GCST90385212 | 0.04 |
| 9453 | WASL levels | GCST90471070 | 0.04 |
| 9454 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditions | UKBB00000100 | 0.04 |
| 9455 | Immature reticulocyte fraction (UKB data field 30280) | GCST90468079 | 0.04 |
| 9456 | Amyotrophic lateral sclerosis | GCST90027164 | 0.04 |
| 9457 | Retention of urine | FING00001257 | 0.04 |
| 9458 | CGA levels | GCST90468732 | 0.04 |
| 9459 | F-salad vegetables liking (derived food-liking factor) | GCST90094824 | 0.04 |
| 9460 | Mouth/teeth dental problems - Bleeding gums | Mouth | UKBB00000485 | 0.04 |
| 9461 | DTI TBSS L2 Medial lemniscus L | GCST90384485 | 0.04 |
| 9462 | METAP2/USP8 ratio | GCST90315434 | 0.04 |
| 9463 | EBAG9 levels | GCST90469059 | 0.04 |
| 9464 | aparc-a2009s lh volume G-precuneus | GCST90002954 | 0.04 |
| 9465 | Other obstetric trauma | FING00001082 | 0.04 |
| 9466 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T57 | ECGA000057 | 0.04 |
| 9467 | PLIN1/SNCG ratio | GCST90315677 | 0.04 |
| 9468 | HippSubfield lh volume GC-ML-DG-head | GCST90002679 | 0.04 |
| 9469 | Phospholipids to total lipids ratio in large HDL | GCST90092853 | 0.04 |
| 9470 | CTRL levels | GCST90468907 | 0.04 |
| 9471 | DTI TBSS FA External capsule L | GCST90384413 | 0.04 |
| 9472 | Substance use, excluding alcohol | FING00001342 | 0.04 |
| 9473 | SDC4/SEMA4D ratio | GCST90315818 | 0.04 |
| 9474 | AV-block | FING00000137 | 0.04 |
| 9475 | CD58/TYRO3 ratio | GCST90313856 | 0.04 |
| 9476 | Cancer of prostate | neoplasms | UKBB00000118 | 0.04 |
| 9477 | Estimated glomerular filtration rate based on creatinine and cystatin C in bottom 99% of individuals by creatinine levels | GCST90566737 | 0.04 |
| 9478 | T1 FreeSurfer aseg Right-Putamen | GCST90384163 | 0.04 |
| 9479 | Skin elastin (cheek, R5) | GCST90502787 | 0.04 |
| 9480 | Viral hepatitis (PheCode 70) | GCST90475552 | 0.04 |
| 9481 | Reticulocyte fraction of red cells | GCST004619 | 0.04 |
| 9482 | IDP dMRI TBSS MD Inferior cerebellar peduncle R | GCST90004037 | 0.04 |
| 9483 | Acute alcohol intoxication, ICD10 | FING00000015 | 0.04 |
| 9484 | DSG3/NECTIN4 ratio | GCST90314560 | 0.04 |
| 9485 | BCL2L11/RAB6A ratio | GCST90313484 | 0.04 |
| 9486 | LDL cholesterol levels (UKB data field 23405) | GCST90269502 | 0.04 |
| 9487 | wg rh intensity-contrast paracentral | GCST90003843 | 0.04 |
| 9488 | Diacylglycerol_36:5_[M+H-H2O]1+ levels | GCST90060187 | 0.04 |
| 9489 | KIRREL2/PLA2G1B ratio | GCST90315251 | 0.04 |
| 9490 | Retinal thickness (functional principal component 1) | GCST90455721 | 0.04 |
| 9491 | Schizophrenia or delusion (more control exclusions) | FING00001278 | 0.04 |
| 9492 | Alcohol use disorder, ICD-based | FING00000052 | 0.04 |
| 9493 | GZMB levels | GCST90469424 | 0.04 |
| 9494 | Feeling fed-up | GCST006947 | 0.04 |
| 9495 | Salty food liking | GCST90094828 | 0.04 |
| 9496 | MMP9/PLAUR ratio | GCST90315470 | 0.04 |
| 9497 | Moderate to vigorous physical activity levels | GCST006097 | 0.04 |
| 9498 | NSFL1C/UBAC1 ratio | GCST90315565 | 0.04 |
| 9499 | EFNB2 levels | GCST90469082 | 0.04 |
| 9500 | Concentration of LDL particles | GCST90092887 | 0.04 |
| 9501 | Salad leaves liking | GCST90094823 | 0.04 |
| 9502 | IDP dMRI ProbtrackX ICVF mcp | GCST90004391 | 0.04 |
| 9503 | Cancer | GCST90086052 | 0.04 |
| 9504 | Right-hemisphere control network to amygdala white-matter structural connectivity | GCST90302841 | 0.04 |
| 9505 | SNAP25 levels | GCST90422083 | 0.04 |
| 9506 | CDH5/LGALS4 ratio | GCST90313956 | 0.04 |
| 9507 | Total lipid levels in medium LDL | GCST90092910 | 0.04 |
| 9508 | CPB1/CTRC ratio | GCST90314209 | 0.04 |
| 9509 | CCL14/CST3 ratio | GCST90313679 | 0.04 |
| 9510 | Nasal polyp | Other diseases of upper respiratory tract | UKBB00000493 | 0.04 |
| 9511 | Treatment speciality of consultant (recoded) - General medicine | Summary Administration | UKBB00000832 | 0.04 |
| 9512 | Intended management of patient (recoded) - One or more nights hospital stay | Summary Administration | UKBB00000367 | 0.04 |
| 9513 | Horseradish liking | GCST90094783 | 0.04 |
| 9514 | NECTIN2/TNFRSF1A ratio | GCST90315532 | 0.04 |
| 9515 | DTI TBSS MO Pontine crossing tract | GCST90384621 | 0.04 |
| 9516 | ADGRE1 levels | GCST90468236 | 0.04 |
| 9517 | Arm fat percentage (right) | Impedance measures | UKBB00000046 | 0.04 |
| 9518 | Deep venous thrombosis | GCST90468122 | 0.04 |
| 9519 | T1 FIRST volume L Puta | GCST90383987 | 0.04 |
| 9520 | Creatinine (enzymatic) in urine | Urine assays | UKBB00000155 | 0.04 |
| 9521 | TEX101 levels | GCST90470832 | 0.04 |
| 9522 | GRAP2/PPP1R2 ratio | GCST90314985 | 0.04 |
| 9523 | Weight | Impedance measures | UKBB00000910 | 0.04 |
| 9524 | Pregnenetriol sulfate levels | GCST90200241 | 0.04 |
| 9525 | GLRX2 levels | GCST90241278 | 0.04 |
| 9526 | KIT levels | GCST90469692 | 0.04 |
| 9527 | HDGF levels | GCST90469442 | 0.04 |
| 9528 | Episodal and paroxysmal disorders | FING00000514 | 0.04 |
| 9529 | CD69/CLEC1B ratio | GCST90313869 | 0.04 |
| 9530 | IDP dMRI TBSS L1 Anterior limb of internal capsule R | GCST90004091 | 0.04 |
| 9531 | STX8/USP8 ratio | GCST90315896 | 0.04 |
| 9532 | aseg lh volume Cerebellum-Cortex | GCST90002619 | 0.04 |
| 9533 | Ever Smoker | FING00000522 | 0.04 |
| 9534 | CALCOCO1/DCTN1 ratio | GCST90313600 | 0.04 |
| 9535 | Total lipids in LDL (UKB data field 23425) | GCST90269522 | 0.04 |
| 9536 | Body mass index (BMI) | Impedance measures | UKBB00000104 | 0.04 |
| 9537 | eGFR in diabetes mellitus (loose) kidney healthy controls (minimal adjustment) | GCST90624778 | 0.04 |
| 9538 | Guilty feelings | Mental health | UKBB00000291 | 0.04 |
| 9539 | HGF/PDGFB ratio | GCST90315058 | 0.04 |
| 9540 | Arm fat mass (left) | Impedance measures | UKBB00000043 | 0.04 |
| 9541 | PDGFB/SDC4 ratio | GCST90315626 | 0.04 |
| 9542 | VSTM2L levels | GCST90471057 | 0.04 |
| 9543 | NPDC1/TAFA5 ratio | GCST90315550 | 0.04 |
| 9544 | CHI3L1 levels | GCST90468743 | 0.04 |
| 9545 | TREM2 levels | GCST90470960 | 0.04 |
| 9546 | Cerebrospinal fluid methylmalonate (MMA) levels | GCST90318243 | 0.04 |
| 9547 | ICAM3/LY9 ratio | GCST90315121 | 0.04 |
| 9548 | F-oily fish liking (derived food-liking factor) | GCST90094804 | 0.04 |
| 9549 | Volume of right accessory basal nucleus | GCST90475009 | 0.04 |
| 9550 | Medication use (drugs used in diabetes) | GCST90018761 | 0.04 |
| 9551 | ACP6 levels | GCST90468204 | 0.04 |
| 9552 | HippSubfield rh volume Whole-hippocampal-head | GCST90002710 | 0.04 |
| 9553 | FUOM levels | GCST90469276 | 0.04 |
| 9554 | Myocardial fractal dimension (slice 3) | GCST90000289 | 0.04 |
| 9555 | CCN4 levels | GCST90468590 | 0.04 |
| 9556 | Gamma glutamyltransferase levels (UKB data field 30730) | GCST90468070 | 0.04 |
| 9557 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T420 | ECGU000420 | 0.04 |
| 9558 | Kela-code for severe mental illness | FING00000707 | 0.04 |
| 9559 | BACH1/PDLIM7 ratio | GCST90313445 | 0.04 |
| 9560 | PGLYRP2 levels | GCST90470220 | 0.04 |
| 9561 | BCL2L11/VASH1 ratio | GCST90313485 | 0.04 |
| 9562 | Arm fat percentage right (UKB data field 23119) | GCST90468158 | 0.04 |
| 9563 | HSPA1A/MGLL ratio | GCST90315083 | 0.04 |
| 9564 | Weight (mean, inv-normal transformed) | GCST90476463 | 0.04 |
| 9565 | Occupational creativity | GCST90308774 | 0.04 |
| 9566 | PLXNA4/SUSD1 ratio | GCST90315689 | 0.04 |
| 9567 | ESAM/PDGFB ratio | GCST90314714 | 0.04 |
| 9568 | MCEMP1 levels | GCST90469872 | 0.04 |
| 9569 | LY6D/WFDC12 ratio | GCST90315346 | 0.04 |
| 9570 | Operation code - caesarean section / caesarian section | Operations | UKBB00000552 | 0.04 |
| 9571 | BACH1/SNX9 ratio | GCST90313447 | 0.04 |
| 9572 | Body mass index | GCST90025994 | 0.04 |
| 9573 | KAZN levels | GCST90469666 | 0.04 |
| 9574 | GGT1 levels | GCST90469336 | 0.04 |
| 9575 | FGA levels | GCST90469216 | 0.04 |
| 9576 | Viral haemorrhagic fevers, not elsewhere classified/unspecified | FING00001433 | 0.04 |
| 9577 | Hearing difficulty/problems with background noise | Hearing | UKBB00000312 | 0.04 |
| 9578 | Glutamine levels | GCST90497282 | 0.04 |
| 9579 | Free cholesterol in very large HDL (UKB data field 23556) | GCST90269653 | 0.04 |
| 9580 | DAB2/LYN ratio | GCST90314365 | 0.04 |
| 9581 | Principal component-derived dietary pattern 36 | GCST90133041 | 0.04 |
| 9582 | PODXL2/SCG3 ratio | GCST90315700 | 0.04 |
| 9583 | Right-hemisphere somatomotor network to pallidum white-matter structural connectivity | GCST90302797 | 0.04 |
| 9584 | Cholesterol to Total Lipids in IDL percentage | GCST90497518 | 0.04 |
| 9585 | Sleeplessness / insomnia | Sleep | UKBB00000778 | 0.04 |
| 9586 | PLXNB2 levels | GCST90470266 | 0.04 |
| 9587 | Other disorders of urethra and urinary system | FING00001039 | 0.04 |
| 9588 | IDP dMRI TBSS ICVF Cerebral peduncle R | GCST90004341 | 0.04 |
| 9589 | DTI autoptx L1 ilf r tract | GCST90385154 | 0.04 |
| 9590 | MGLL/PTPN6 ratio | GCST90315440 | 0.04 |
| 9591 | Cholesteryl esters to total lipids ratio in large HDL | GCST90092847 | 0.04 |
| 9592 | Haemoglobin concentration | Blood count | UKBB00000293 | 0.04 |
| 9593 | Platelet count during first trimester of pregnancy | GCST90302224 | 0.04 |
| 9594 | Total free cholesterol levels (UKB data field 23419) | GCST90269516 | 0.03 |
| 9595 | Creatinine levels | GCST90497236 | 0.03 |
| 9596 | DTI autoptx L1 slf r tract | GCST90385161 | 0.03 |
| 9597 | Alcohol consumption (drinks per month) (UKB data field 1578, 4424) | GCST90132992 | 0.03 |
| 9598 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T279 | ECGU000279 | 0.03 |
| 9599 | HippSubfield lh volume molecular-layer-HP-head | GCST90002677 | 0.03 |
| 9600 | IDP dMRI TBSS FA Cingulum cingulate gyrus R | GCST90003911 | 0.03 |
| 9601 | MOG levels | GCST90469929 | 0.03 |
| 9602 | F-healthy food liking (derived food-liking factor) | GCST90094779 | 0.03 |
| 9603 | Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levels | GCST90060557 | 0.03 |
| 9604 | Enlarged prostate (Benign prostatic hyperplasia) | GCST90475261 | 0.03 |
| 9605 | Type 2 diabetes with ophthalmic manifestations (PheCode 250.23) | GCST90475673 | 0.03 |
| 9606 | IL17A levels | GCST90469558 | 0.03 |
| 9607 | PDGFA/SCARF1 ratio | GCST90315617 | 0.03 |
| 9608 | Total lipid levels in IDL | GCST90132633 | 0.03 |
| 9609 | IDP dMRI TBSS L3 Superior cerebellar peduncle R | GCST90004183 | 0.03 |
| 9610 | Glucose (fasting status unknown, mean, inv-norm transformed) | GCST90475332 | 0.03 |
| 9611 | CHGA levels | GCST90468741 | 0.03 |
| 9612 | Smoking status, ever vs never | Other measurement | UKBB00000782 | 0.03 |
| 9613 | Phosphoglycerides levels | GCST90092938 | 0.03 |
| 9614 | HBEGF/WWP2 ratio | GCST90315038 | 0.03 |
| 9615 | Mid-point of the five least active hours of the day | GCST90061434 | 0.03 |
| 9616 | PLA2G1B levels | GCST90470246 | 0.03 |
| 9617 | Lifespan | GCST90551884 | 0.03 |
| 9618 | Number of sexual partners in opposite-sex sexual behavior | GCST90026481 | 0.03 |
| 9619 | Infective dermatitis | FING00000673 | 0.03 |
| 9620 | LDL cholesterol | GCST90018741 | 0.03 |
| 9621 | Total esterified cholesterol levels | GCST90092986 | 0.03 |
| 9622 | CD300C/GOLM2 ratio | GCST90313788 | 0.03 |
| 9623 | Medication use (glucocorticoids) | GCST90018780 | 0.03 |
| 9624 | Physical activity (Total log acceleration 6am-8am) | GCST90061412 | 0.03 |
| 9625 | APOC1 levels | GCST90468336 | 0.03 |
| 9626 | Pre-existing hypertension complicating pregnancy, childbirth and the puerperium | FING00001203 | 0.03 |
| 9627 | Processed meat intake | Diet | UKBB00000711 | 0.03 |
| 9628 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T174 | ECGA000174 | 0.03 |
| 9629 | RTBDN levels | GCST90470505 | 0.03 |
| 9630 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T277 | ECGA000277 | 0.03 |
| 9631 | Cereal type: Muesli (UKB data field 1468_4) | GCST90132972 | 0.03 |
| 9632 | T1 CAT volume L LateralOccipitalCortexinferiordivision | GCST90384044 | 0.03 |
| 9633 | Cholesteryl Esters to Total Lipids in Medium VLDL percentage | GCST90498956 | 0.03 |
| 9634 | ATRAID levels | GCST90468399 | 0.03 |
| 9635 | CXCL16 levels | GCST90240524 | 0.03 |
| 9636 | Chronotype | GCST003837 | 0.03 |
| 9637 | DAG1/SCARF1 ratio | GCST90314381 | 0.03 |
| 9638 | Free testosterone levels | GCST90239825 | 0.03 |
| 9639 | EPHA1 levels | GCST90469129 | 0.03 |
| 9640 | Cardiorespiratory fitness (vo2 max) | GCST90093316 | 0.03 |
| 9641 | Psoriasis (vulgaris), strict definition | FING00001223 | 0.03 |
| 9642 | SNX9/VASH1 ratio | GCST90315866 | 0.03 |
| 9643 | HSD17B14 levels | GCST90469483 | 0.03 |
| 9644 | CCR2 on CD14+ CD16- monocyte | GCST90002004 | 0.03 |
| 9645 | REST UKBBICA NODEamps25 0003 | GCST90385486 | 0.03 |
| 9646 | neutrophil (absolute count, mean, inv-norm transformed) | GCST90475529 | 0.03 |
| 9647 | Hemoglobin | GCST90002384 | 0.03 |
| 9648 | IGFBPL1 levels | GCST90179323 | 0.03 |
| 9649 | Free Cholesterol to Total Lipids in Medium LDL percentage | GCST90498783 | 0.03 |
| 9650 | CCN2/SPINT2 ratio | GCST90313716 | 0.03 |
| 9651 | FOXO1/USP8 ratio | GCST90314879 | 0.03 |
| 9652 | Bread consumption (slices per week) (UKB data field 1438) | GCST90132981 | 0.03 |
| 9653 | F-savour/caloric food liking (derived food-liking factor) | GCST90094835 | 0.03 |
| 9654 | Creatinine levels | GCST90497237 | 0.03 |
| 9655 | Dementia due to Parkinson's disease (more control exclusions) | FING00000392 | 0.03 |
| 9656 | Linoleic acid to total fatty acids percentage | GCST90498321 | 0.03 |
| 9657 | SAP18 levels | GCST90241432 | 0.03 |
| 9658 | Glycine levels | GCST90497316 | 0.03 |
| 9659 | KLK6/PTPRN2 ratio | GCST90315256 | 0.03 |
| 9660 | CA5A levels | GCST90468514 | 0.03 |
| 9661 | Phospholipid levels in IDL | GCST90092839 | 0.03 |
| 9662 | C1QTNF9 levels | GCST90468491 | 0.03 |
| 9663 | PCDH9 levels | GCST90470172 | 0.03 |
| 9664 | COMP/TGFBI ratio | GCST90314192 | 0.03 |
| 9665 | Smoking status - Never | Smoking | UKBB00000780 | 0.03 |
| 9666 | Qualifications - O levels/GCSEs or equivalent | Education | UKBB00000731 | 0.03 |
| 9667 | CPB1/KIRREL2 ratio | GCST90314210 | 0.03 |
| 9668 | Active to sedentary transition probability | GCST90061429 | 0.03 |
| 9669 | Sporadic miscarriage | GCST011888 | 0.03 |
| 9670 | Effects radiation NOS (PheCode 990) | GCST90476293 | 0.03 |
| 9671 | Acute peritonitis | FING00000028 | 0.03 |
| 9672 | Leisure/social activities - None of the above | Social support | UKBB00000399 | 0.03 |
| 9673 | Stearoylcarnitine (C18) levels | GCST90199743 | 0.03 |
| 9674 | Number of incorrect matches in round | Pairs matching | UKBB00000538 | 0.03 |
| 9675 | ALCAM/SPINT1 ratio | GCST90313242 | 0.03 |
| 9676 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T454 | ECGA000454 | 0.03 |
| 9677 | Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144) | GCST90132931 | 0.03 |
| 9678 | Weight | Body size measures | UKBB00000909 | 0.03 |
| 9679 | Lymphoid neoplasms (somatic mutation group 2 phenocluster) | GCST90624750 | 0.03 |
| 9680 | Free cholesterol in small HDL | GCST90499425 | 0.03 |
| 9681 | BA-exvivo lh area BA6 | GCST90003213 | 0.03 |
| 9682 | CEP112 levels | GCST90468708 | 0.03 |
| 9683 | CD27/TNFRSF13B ratio | GCST90313777 | 0.03 |
| 9684 | T1 FreeSurfer DKT rh pericalcarine area | GCST90384305 | 0.03 |
| 9685 | OBP2B levels | GCST90470113 | 0.03 |
| 9686 | Nasal polyps | GCST90468143 | 0.03 |
| 9687 | AmygNuclei lh volume Central-nucleus | GCST90002652 | 0.03 |
| 9688 | Triglyceride levels in HDL | GCST90092829 | 0.03 |
| 9689 | BST2/MME ratio | GCST90313539 | 0.03 |
| 9690 | Cholesteryl ester levels in medium VLDL | GCST90092918 | 0.03 |
| 9691 | DIPK2B levels | GCST90468996 | 0.03 |
| 9692 | Diverticulitis | GCST90468125 | 0.03 |
| 9693 | Cholesteryl esters in LDL (UKB data field 23417) | GCST90269514 | 0.03 |
| 9694 | EDAR/ERBIN ratio | GCST90314575 | 0.03 |
| 9695 | CD164/SIAE ratio | GCST90313744 | 0.03 |
| 9696 | TBCB/TBCC ratio | GCST90315909 | 0.03 |
| 9697 | Fasting glucose | GCST90002231 | 0.03 |
| 9698 | HSPB1/PLIN3 ratio | GCST90315088 | 0.03 |
| 9699 | BCR/DECR1 ratio | GCST90313489 | 0.03 |
| 9700 | DECR1/FXN ratio | GCST90314446 | 0.03 |
| 9701 | Gout (PheCode 274.1) | GCST90475735 | 0.03 |
| 9702 | DPEP1 levels | GCST90469030 | 0.03 |
| 9703 | CPM/LAMP2 ratio | GCST90314215 | 0.03 |
| 9704 | Job involves mainly walking or standing | Employment | UKBB00000384 | 0.03 |
| 9705 | CRTAM/LY9 ratio | GCST90314278 | 0.03 |
| 9706 | CD74/NPDC1 ratio | GCST90313895 | 0.03 |
| 9707 | Total lipids in small LDL | GCST90499652 | 0.03 |
| 9708 | CPXM1/VEGFC ratio | GCST90314223 | 0.03 |
| 9709 | Epilepsy | FING00000511 | 0.03 |
| 9710 | PDGFA/VEGFC ratio | GCST90315622 | 0.03 |
| 9711 | Urbanicity (confirmatory factor analysis Factor 4) | GCST90309339 | 0.03 |
| 9712 | DTI TBSS L2 Tapetum L | GCST90384523 | 0.03 |
| 9713 | Hemoglobin concentration | GCST90002310 | 0.03 |
| 9714 | Metabolic syndrome | GCST90444487 | 0.03 |
| 9715 | Sedentary behavior at work | GCST90104345 | 0.03 |
| 9716 | Preterm labour and delivery | FING00001209 | 0.03 |
| 9717 | Total fatty acid levels | GCST90502212 | 0.03 |
| 9718 | CX3CL1/EPHB6 ratio | GCST90314324 | 0.03 |
| 9719 | Triglyceride levels in IDL | GCST90092841 | 0.03 |
| 9720 | F12 levels | GCST90469166 | 0.03 |
| 9721 | Cognitive performance | GCST006572 | 0.03 |
| 9722 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T219 | ECGA000219 | 0.03 |
| 9723 | SLC39A14 levels | GCST90470660 | 0.03 |
| 9724 | Osteoarthrosis NOS (PheCode 740.9) | GCST90476256 | 0.03 |
| 9725 | Phospholipids to Total Lipids in Medium LDL percentage | GCST90498852 | 0.03 |
| 9726 | APOB levels | GCST90092809 | 0.03 |
| 9727 | CLEC4D/TGFA ratio | GCST90314117 | 0.03 |
| 9728 | SCARA5/TGFBI ratio | GCST90315809 | 0.03 |
| 9729 | Phospholipid levels in large LDL | GCST90132648 | 0.03 |
| 9730 | Multiple system atrophy | GCST90406925 | 0.03 |
| 9731 | Thyroid peroxidase antibody positivity in pregnancy | GCST90435202 | 0.03 |
| 9732 | BA-exvivo lh area BA3b | GCST90003210 | 0.03 |
| 9733 | LY96 levels | GCST90469823 | 0.03 |
| 9734 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T427 | ECGU000427 | 0.03 |
| 9735 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T179 | ECGA000179 | 0.03 |
| 9736 | IDP dMRI TBSS L3 Inferior cerebellar peduncle R | GCST90004181 | 0.03 |
| 9737 | NFKB1 levels | GCST90470037 | 0.03 |
| 9738 | Left-hemisphere limbic network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302731 | 0.03 |
| 9739 | Free cholesterol levels in large LDL | GCST003665 | 0.03 |
| 9740 | DTI TBSS L3 Anterior limb of internal capsule L | GCST90384541 | 0.03 |
| 9741 | Drink temperature | GCST90133002 | 0.03 |
| 9742 | Operation code - hysterectomy | Operations | UKBB00000559 | 0.03 |
| 9743 | ANXA10 levels | GCST90468314 | 0.03 |
| 9744 | Nontoxic diffuse goitre | FING00000886 | 0.03 |
| 9745 | Other hearing loss | FING00001056 | 0.03 |
| 9746 | Flavonifractor sp002159265 abundance in stool | GCST90032400 | 0.03 |
| 9747 | FOXO1/MAP4K5 ratio | GCST90314872 | 0.03 |
| 9748 | Other/unspecified rheumatoid arthritis | FING00001126 | 0.03 |
| 9749 | platelet count (maximum, inv-norm transformed) | GCST90476296 | 0.03 |
| 9750 | Annual healthcare cost | GCST90292604 | 0.03 |
| 9751 | IDP T1 FIRST right caudate volume | GCST90002439 | 0.03 |
| 9752 | Plasma taurocholenate sulfate* levels in chronic kidney disease | GCST90266040 | 0.03 |
| 9753 | T1 FreeSurfer aseg CC Posterior | GCST90384175 | 0.03 |
| 9754 | APP/CCL28 ratio | GCST90313317 | 0.03 |
| 9755 | Gout (PheCode 274.1) | GCST90476379 | 0.03 |
| 9756 | Takes medication for circulatory problem? | GCST90475218 | 0.03 |
| 9757 | Total cholesterol levels | GCST90092985 | 0.03 |
| 9758 | Hypertension | GCST90086091 | 0.03 |
| 9759 | SUSD5 levels | GCST90470789 | 0.03 |
| 9760 | Concentration of large LDL particles | GCST90092863 | 0.03 |
| 9761 | Alzheimer's disease or family history of Alzheimer's disease | GCST90012877 | 0.03 |
| 9762 | FCER2/FCRL1 ratio | GCST90314789 | 0.03 |
| 9763 | DTI TBSS L1 Genu of corpus callosum | GCST90384430 | 0.03 |
| 9764 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T243 | ECGU000243 | 0.03 |
| 9765 | LGMN/TIMP1 ratio | GCST90315325 | 0.03 |
| 9766 | aparc-pial lh area parstriangularis | GCST90003160 | 0.03 |
| 9767 | Unspecified dementia | FING00001400 | 0.03 |
| 9768 | FGF21 levels | GCST90469222 | 0.03 |
| 9769 | magnesium (Mg, maximum, inv-norm transformed) | GCST90475477 | 0.03 |
| 9770 | ELOA/POLR2F ratio | GCST90314643 | 0.03 |
| 9771 | Lymphoid neoplasms (P-cell phenocluster) | GCST90624737 | 0.03 |
| 9772 | TNFRSF14 levels | GCST90470907 | 0.03 |
| 9773 | DCXR/GSTA1 ratio | GCST90314437 | 0.03 |
| 9774 | aparc-pial rh area precuneus | GCST90003198 | 0.03 |
| 9775 | Gout and other crystal arthrop (PheCode 274) | GCST90475731 | 0.03 |
| 9776 | KLK6 levels | GCST90469705 | 0.03 |
| 9777 | OSM/TGFA ratio | GCST90315590 | 0.03 |
| 9778 | MAVS/ZBTB16 ratio | GCST90315401 | 0.03 |
| 9779 | FOLR3/KLK8 ratio | GCST90314868 | 0.03 |
| 9780 | SCT levels | GCST90470557 | 0.03 |
| 9781 | Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636) | GCST90269733 | 0.03 |
| 9782 | Non-albumin protein levels | UKBB00000503 | 0.03 |
| 9783 | Free Cholesterol to Total Lipids in Large LDL percentage | GCST90498000 | 0.03 |
| 9784 | DTI TBSS L3 Superior cerebellar peduncle R | GCST90384536 | 0.03 |
| 9785 | Asthma (adult onset) | GCST007799 | 0.03 |
| 9786 | Triglycerides to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23583) | GCST90269680 | 0.03 |
| 9787 | Cholesterol to Total Lipids in Small LDL percentage | GCST90499569 | 0.03 |
| 9788 | Free cholesterol to total lipids ratio in small LDL | GCST90092961 | 0.03 |
| 9789 | F-sweetened coffee drink liking (derived food-liking factor) | GCST90094853 | 0.03 |
| 9790 | Total phospholipid levels in lipoprotein particles | GCST90092991 | 0.03 |
| 9791 | Mean platelet volume | GCST004599 | 0.03 |
| 9792 | Total cholesterol minus HDL-C levels (UKB data field 23401) | GCST90269498 | 0.03 |
| 9793 | Medication for pain relief, constipation, heartburn - Omeprazole (e.g. Zanprol) | Medication | UKBB00000458 | 0.03 |
| 9794 | Liver enzyme levels (gamma-glutamyl transferase) | GCST90013407 | 0.03 |
| 9795 | CD83/TNFRSF4 ratio | GCST90313907 | 0.03 |
| 9796 | N-acetyltaurine levels | GCST90199967 | 0.03 |
| 9797 | Body mass index | GCST90428119 | 0.03 |
| 9798 | OMD/SOST ratio | GCST90315585 | 0.03 |
| 9799 | Cholesterol levels in very small VLDL | GCST90093028 | 0.03 |
| 9800 | ALB/Globulin ratio | UKBB00000020 | 0.03 |
| 9801 | CD300C/FOLR2 ratio | GCST90313787 | 0.03 |
| 9802 | Other anxiety disorders | FING00000960 | 0.03 |
| 9803 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T280 | ECGA000280 | 0.03 |
| 9804 | Oral glucose tolerance test-2h | GCST90566423 | 0.03 |
| 9805 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T278 | ECGA000278 | 0.03 |
| 9806 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T439 | ECGU000439 | 0.03 |
| 9807 | IDP T1 FAST ROIs R thalamus | GCST90002548 | 0.03 |
| 9808 | EBAG9/FKBP5 ratio | GCST90314564 | 0.03 |
| 9809 | Acetone levels (UKB data field 23477) | GCST90269574 | 0.03 |
| 9810 | LAT/PDGFA ratio | GCST90315285 | 0.03 |
| 9811 | TNFSF10 levels | GCST90012011 | 0.03 |
| 9812 | Creatinine levels (UKB data field 30700) | GCST90468067 | 0.03 |
| 9813 | FABP4/SNCG ratio | GCST90314759 | 0.03 |
| 9814 | FHIT/PRTFDC1 ratio | GCST90314823 | 0.03 |
| 9815 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T230 | ECGU000230 | 0.03 |
| 9816 | Estimated glomerular filtration rate (creatinine) | GCST90428447 | 0.03 |
| 9817 | TACC3/TBC1D23 ratio | GCST90315900 | 0.03 |
| 9818 | Pyruvate levels | GCST90092942 | 0.03 |
| 9819 | IDP dMRI ProbtrackX ISOVF cgc r | GCST90004530 | 0.03 |
| 9820 | wg lh intensity-contrast postcentral | GCST90003813 | 0.03 |
| 9821 | Asthma | Chronic lower respiratory diseases | UKBB00000053 | 0.03 |
| 9822 | Dried fruit consumption | GCST90132980 | 0.03 |
| 9823 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T481 | ECGA000481 | 0.03 |
| 9824 | Linoleic acid levels | GCST90502012 | 0.03 |
| 9825 | IDP T1 SIENAX brain-normalised volume | GCST90002434 | 0.03 |
| 9826 | Average diameter for HDL particles | GCST90132702 | 0.03 |
| 9827 | Family relationship satisfaction | Mental health | UKBB00000238 | 0.03 |
| 9828 | ADAMTS15 levels | GCST90468223 | 0.03 |
| 9829 | rfMRI amplitudes (ICA100 node 44) | GCST90004632 | 0.03 |
| 9830 | MGLL/PLA2G4A ratio | GCST90315439 | 0.03 |
| 9831 | aparc-DKTatlas lh area fusiform | GCST90003239 | 0.03 |
| 9832 | IDP T1 SIENAX brain-unnormalised volume | GCST90002435 | 0.03 |
| 9833 | WFDC5 levels | GCST90089598 | 0.03 |
| 9834 | Polyunsaturated fatty acid levels | GCST90502134 | 0.03 |
| 9835 | Creatinine levels | GCST90025946 | 0.03 |
| 9836 | Acute pulmonary heart disease (PheCode 415.1) | GCST90475944 | 0.03 |
| 9837 | X-17357 levels | GCST90200550 | 0.03 |
| 9838 | LDL direct | Blood biochemistry | UKBB00000386 | 0.03 |
| 9839 | DAB2/FKBP1B ratio | GCST90314362 | 0.03 |
| 9840 | Body mass index (BMI) | Body size measures | UKBB00000103 | 0.03 |
| 9841 | Leisure/social activities - Pub or social club | Social support | UKBB00000401 | 0.03 |
| 9842 | Alkenylphosphatidylcholine (P-36:3) levels | GCST90024954 | 0.03 |
| 9843 | ESAM/SORT1 ratio | GCST90314716 | 0.03 |
| 9844 | Leg fat mass (right) | Impedance measures | UKBB00000390 | 0.03 |
| 9845 | EFNA4/LAYN ratio | GCST90314602 | 0.03 |
| 9846 | Cholesterol to Total Lipids in Medium LDL percentage | GCST90498714 | 0.03 |
| 9847 | Right-hemisphere somatomotor network to right-hemisphere default mode network white-matter structural connectivity | GCST90302793 | 0.03 |
| 9848 | MESD/VASH1 ratio | GCST90315425 | 0.03 |
| 9849 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T478 | ECGA000478 | 0.03 |
| 9850 | IDP dMRI TBSS L1 Posterior limb of internal capsule R | GCST90004093 | 0.03 |
| 9851 | Suffer from 'nerves' | Mental health | UKBB00000799 | 0.03 |
| 9852 | aparc-a2009s rh thickness G-oc-temp-med-Lingual | GCST90003698 | 0.03 |
| 9853 | Gamma-glutamylglycine levels | GCST90199741 | 0.03 |
| 9854 | Right-hemisphere dorsal attention network to thalamus white-matter structural connectivity | GCST90302806 | 0.03 |
| 9855 | Monocyte count | GCST004625 | 0.03 |
| 9856 | IDP dMRI TBSS MO Superior corona radiata L | GCST90003977 | 0.03 |
| 9857 | KITLG levels | GCST90428432 | 0.03 |
| 9858 | CEACAM8/VNN2 ratio | GCST90314005 | 0.03 |
| 9859 | IBD (strict) with PSC | FING00000657 | 0.03 |
| 9860 | Graves' disease | GCST90018627 | 0.03 |
| 9861 | CTRB1/KIRREL2 ratio | GCST90314306 | 0.03 |
| 9862 | T1 FreeSurfer a2009s rh S calcarine area | GCST90384933 | 0.03 |
| 9863 | Principal component-derived dietary pattern 29 | GCST90133034 | 0.03 |
| 9864 | BSG/PCDH1 ratio | GCST90313535 | 0.03 |
| 9865 | Eosinophil percentage of white cells variance | GCST90565690 | 0.03 |
| 9866 | aparc-Desikan rh volume postcentral | GCST90002822 | 0.03 |
| 9867 | Obesity related asthma | FING00000897 | 0.03 |
| 9868 | Visceral adipose tissue normalized | GCST90267358 | 0.03 |
| 9869 | Leg fat mass (left) | Impedance measures | UKBB00000389 | 0.03 |
| 9870 | SERPINI2 levels | GCST90470603 | 0.03 |
| 9871 | CHGA levels | GCST90240699 | 0.03 |
| 9872 | Free Cholesterol to Total Lipids in Small LDL percentage | GCST90499635 | 0.03 |
| 9873 | Left-hemisphere somatomotor network to left-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302671 | 0.03 |
| 9874 | FRZB levels | GCST90469269 | 0.03 |
| 9875 | CST3/RARRES2 ratio | GCST90314295 | 0.03 |
| 9876 | Hallux rigidus | FING00000600 | 0.03 |
| 9877 | Creatinine levels | GCST90278624 | 0.03 |
| 9878 | Type 2 diabetes | GCST90018706 | 0.03 |
| 9879 | PM20D1 levels | GCST90470268 | 0.03 |
| 9880 | Extrapyramidal disease and abnormal movement disorders (PheCode 333) | GCST90475831 | 0.03 |
| 9881 | Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498919 | 0.03 |
| 9882 | Other bacterial intestinal infections | FING00000969 | 0.03 |
| 9883 | HDL cholesterol levels (UKB data field 30760) | GCST90468075 | 0.03 |
| 9884 | rfMRI connectivity (ICA100 edge 995) | GCST90005848 | 0.03 |
| 9885 | TGFBR2/THBD ratio | GCST90315916 | 0.03 |
| 9886 | Biological Grandparent (maternal): Alzheimer's / Other Dementia | GCST90475484 | 0.03 |
| 9887 | Alcohol use disorder, Swedish definition | FING00000053 | 0.03 |
| 9888 | F-strong vegetable liking (derived food-liking factor) | GCST90094852 | 0.03 |
| 9889 | PPIF levels | GCST90470293 | 0.03 |
| 9890 | X-24406 metabolite level | GCST90616789 | 0.03 |
| 9891 | Cystatin C levels in bottom 99% of individuals by creatinine levels | GCST90566734 | 0.03 |
| 9892 | Age when finished full-time education (standard GWA) | GCST90267280 | 0.03 |
| 9893 | Triglyceride levels in large LDL | GCST90092866 | 0.03 |
| 9894 | SLITRK1 levels | GCST90470669 | 0.03 |
| 9895 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T284 | ECGA000284 | 0.03 |
| 9896 | Creatinine levels in bottom 99% of individuals by creatinine levels | GCST90566733 | 0.03 |
| 9897 | Creatinine | Blood biochemistry | UKBB00000156 | 0.03 |
| 9898 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66) | GCST90320629 | 0.03 |
| 9899 | Pancreas fat | GCST90016675 | 0.03 |
| 9900 | Coffee type: Decaffeinated coffee (any type) (UKB data field 1508_1) | GCST90132974 | 0.03 |
| 9901 | Right bundle branch block (PheCode 426.31) | GCST90475957 | 0.03 |
| 9902 | Weight (UKB data field 21002) | GCST90468183 | 0.03 |
| 9903 | Cereal type - Other (e.g. Cornflakes, Frosties) | Diet | UKBB00000125 | 0.03 |
| 9904 | Prostate cancer | GCST90011808 | 0.03 |
| 9905 | ALDH1A1/CA3 ratio | GCST90313244 | 0.03 |
| 9906 | Random glucose levels | GCST90271557 | 0.03 |
| 9907 | Polyunsaturated fatty acid levels | GCST90092939 | 0.03 |
| 9908 | PCSK9 levels | GCST90428110 | 0.03 |
| 9909 | Depression or dysthymia | FING00000400 | 0.03 |
| 9910 | Estimated glomerular filtration rate, serum creatinine | Other measurement | UKBB00000212 | 0.03 |
| 9911 | IDP dMRI TBSS FA Superior cerebellar peduncle L | GCST90003890 | 0.03 |
| 9912 | Phospholipids in large LDL | GCST90498053 | 0.03 |
| 9913 | Past tobacco smoking | Smoking | UKBB00000635 | 0.03 |
| 9914 | Urine betaine levels in chronic kidney disease | GCST90264859 | 0.03 |
| 9915 | HippSubfield lh volume hippocampal-fissure | GCST90002672 | 0.03 |
| 9916 | Osteoarthrosis (PheCode 740) | GCST90476253 | 0.03 |
| 9917 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T175 | ECGA000175 | 0.03 |
| 9918 | Phosphatidate_34:2_[M-H]1- levels | GCST90060223 | 0.03 |
| 9919 | CD83 levels | GCST90468652 | 0.03 |
| 9920 | Left-hemisphere control network to hippocampus white-matter structural connectivity | GCST90302756 | 0.03 |
| 9921 | Percentage of trisyalated structures in total plasma glycans (GP97) | GCST90668541 | 0.03 |
| 9922 | PDGFB/USP8 ratio | GCST90315633 | 0.03 |
| 9923 | T1 FreeSurfer BA rh BA2 exvivo volume | GCST90385576 | 0.03 |
| 9924 | TFF1/TFF2 ratio | GCST90315914 | 0.03 |
| 9925 | CXCL9 levels | GCST90274784 | 0.03 |
| 9926 | Thyroid peroxidase antibody positivity with euthyroid in pregnancy | GCST90435203 | 0.03 |
| 9927 | CD33 levels | GCST90468625 | 0.03 |
| 9928 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T480 | ECGA000480 | 0.03 |
| 9929 | AMBP/HYOU1 ratio | GCST90313255 | 0.03 |
| 9930 | L1CAM/SEZ6L ratio | GCST90315266 | 0.03 |
| 9931 | wg lh intensity-contrast cuneus | GCST90003796 | 0.03 |
| 9932 | ALCAM/LRRC25 ratio | GCST90313239 | 0.03 |
| 9933 | Cereal intake | Diet | UKBB00000121 | 0.03 |
| 9934 | PIK3IP1/TNFRSF1B ratio | GCST90315654 | 0.03 |
| 9935 | COVID-19 vaccination | GCST90255613 | 0.03 |
| 9936 | Waist circumference (UKB data field 48) | GCST90468182 | 0.03 |
| 9937 | Lysine levels | GCST90200402 | 0.03 |
| 9938 | Resting heart rate | GCST90278636 | 0.03 |
| 9939 | IDP dMRI TBSS MD Superior cerebellar peduncle R | GCST90004039 | 0.03 |
| 9940 | Polyunsaturated fatty acid levels | GCST90502140 | 0.03 |
| 9941 | C4BPB/ENTPD5 ratio | GCST90313556 | 0.03 |
| 9942 | Platelet count during postpartum period | GCST90302228 | 0.03 |
| 9943 | Plasma pregnenetriol disulfate* levels in chronic kidney disease | GCST90265864 | 0.03 |
| 9944 | IDS levels | GCST90469507 | 0.03 |
| 9945 | Depression | FING00000398 | 0.03 |
| 9946 | WAS levels | GCST90471071 | 0.03 |
| 9947 | Total cholesterol levels in small LDL | GCST90132690 | 0.03 |
| 9948 | Triglyceride levels in small VLDL | GCST90092978 | 0.03 |
| 9949 | Left ventricular outflow tract obstruction, narrow definition | FING00000718 | 0.03 |
| 9950 | Urate levels (UKB data field 30880) | GCST90468107 | 0.03 |
| 9951 | Asthma-related acute respiratory infections | FING00000117 | 0.03 |
| 9952 | Immature reticulocyte fraction | Blood count | UKBB00000355 | 0.03 |
| 9953 | FOLR2/THY1 ratio | GCST90314867 | 0.03 |
| 9954 | Retinal thickness (functional principal component 4) | GCST90455724 | 0.03 |
| 9955 | GNLY/GZMA ratio | GCST90314949 | 0.03 |
| 9956 | HTRA2/TRIAP1 ratio | GCST90315099 | 0.03 |
| 9957 | Triglyceride levels in LDL | GCST90092890 | 0.03 |
| 9958 | Glycine levels | GCST90200707 | 0.03 |
| 9959 | CPVL levels | GCST90468848 | 0.03 |
| 9960 | OXT levels | GCST90470139 | 0.03 |
| 9961 | IDP T1 FIRST left hippocampus volume | GCST90002444 | 0.03 |
| 9962 | Clinical anxiety and depression (confirmatory factor analysis Factor 3) | GCST90309338 | 0.03 |
| 9963 | CA4/TGFBR2 ratio | GCST90313588 | 0.03 |
| 9964 | Risk taking | Mental health | UKBB00000759 | 0.03 |
| 9965 | High light scatter reticulocyte percentage of red cells | GCST004612 | 0.03 |
| 9966 | aparc-DKTatlas lh area postcentral | GCST90003254 | 0.03 |
| 9967 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T477 | ECGA000477 | 0.03 |
| 9968 | F-healthy breakfast food liking (derived food-liking factor) | GCST90094780 | 0.03 |
| 9969 | Physical activity | GCST90093323 | 0.03 |
| 9970 | Gallbladder polyp | GCST90018626 | 0.03 |
| 9971 | IDP dMRI TBSS L2 Inferior cerebellar peduncle R | GCST90004133 | 0.03 |
| 9972 | Cholesteryl ester levels in very small VLDL | GCST90093030 | 0.03 |
| 9973 | Monounsaturated fatty acid levels | GCST90092928 | 0.03 |
| 9974 | Phospholipids to Total Lipids in Small LDL percentage | GCST90499700 | 0.03 |
| 9975 | NUB1/SRPK2 ratio | GCST90315573 | 0.03 |
| 9976 | Rheumatoid arthritis | GCST000679 | 0.03 |
| 9977 | IL6 expression at 6 weeks in whole blood upon Bbmix moi30 stimulation in Lyme borreliosis | GCST90275789 | 0.03 |
| 9978 | Body mass index (BMI, mean, inv-normal transformed) | GCST90475156 | 0.03 |
| 9979 | HVEM on Terminally Differentiated CD4+ T cell | GCST90001879 | 0.03 |
| 9980 | How are people in household related to participant - Husband, wife or partner | Household | UKBB00000330 | 0.03 |
| 9981 | Omega-6 fatty acid levels | GCST90502095 | 0.03 |
| 9982 | Free cholesterol to total lipids in very small VLDL percentage (UKB data field 23607) | GCST90269704 | 0.03 |
| 9983 | ELN levels | GCST90469103 | 0.03 |
| 9984 | ANXA4/FADD ratio | GCST90313291 | 0.03 |
| 9985 | Mean corpuscular haemoglobin concentration (UKB data field 30060) | GCST90468085 | 0.03 |
| 9986 | MYOM3 levels | GCST90469986 | 0.03 |
| 9987 | CD209/CLEC14A ratio | GCST90313749 | 0.03 |
| 9988 | Sphingomyelin (d18:0/16:0) levels | GCST90025741 | 0.03 |
| 9989 | Skin cancer | GCST90475575 | 0.03 |
| 9990 | Right-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302816 | 0.03 |
| 9991 | CSRP3 levels | GCST90468892 | 0.03 |
| 9992 | PTPRM/SELE ratio | GCST90315753 | 0.03 |
| 9993 | Free Cholesterol to Total Lipids in IDL percentage | GCST90497579 | 0.03 |
| 9994 | DTI TBSS MD Cingulum cingulate gyrus R | GCST90384606 | 0.03 |
| 9995 | IL12A or IL12B levels | GCST90469548 | 0.03 |
| 9996 | Kiwi liking | GCST90094788 | 0.03 |
| 9997 | Red blood cell (erythrocyte) distribution width | Blood count | UKBB00000748 | 0.03 |
| 9998 | Lupus erythematosus | FING00000739 | 0.03 |
| 9999 | Diabetes, insulin treatment (Kela reimbursement) (more control exclusions) | FING00000410 | 0.03 |
| 10000 | Urate | Blood biochemistry | UKBB00000884 | 0.03 |